NKAP Activators
NKAP Activators comprise a diverse set of chemical compounds that indirectly promote the functionality of NKAP through various signaling pathways. Forskolin, for instance, by raising intracellular cAMP, indirectly augments NKAP's role in transcriptional repression by activating PKA, which in turn could have downstream effects on NKAP's activity. Similarly, PMA, through PKC activation, may indirectly enhance NKAP's involvement in modulating immune responses, a critical aspect of NKAP's function. Ionomycin and A23187, by increasing intracellular calcium, can activate calcium-dependent pathways, potentially bolstering NKAP's regulation of immune cell activities, while Sphingosine-1-phosphate specifically supports NKAP's role in lymphocyte trafficking.
Further, the role of NKAP in immune surveillance and T-cell maturation is indirectly supported by compounds that influence MAPK-related signaling. U0126 and SB203580, by inhibiting MEK and p38 MAPK respectively, have the potential to shift signaling pathways in a manner that favors NKAP's regulatory activities. LY294002 and Wortmannin, both PI3K inhibitors, could also indirectly assist in enhancing NKAP's control over immune cell signaling pathways. Additionally, IBMX and Zaprinast, by inhibiting phosphodiesterases and thus increasing cAMP levels, could indirectly support NKAP's role in transcriptional regulation, further contributing to the enhancement of NKAP mediated functions without necessitating the upregulation of its expression or direct activation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing the intracellular levels of cAMP. Elevated cAMP activates PKA, which can phosphorylate targets that may enhance NKAP's role in transcriptional repression and immune response regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may lead to phosphorylation events that could bolster NKAP's activity in modulating the immune response. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
By increasing intracellular calcium levels, Ionomycin can activate calcium-dependent signaling pathways, potentially enhancing NKAP's involvement in the regulation of immune cell activities. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can activate sphingosine-1-phosphate receptors, which may positively influence NKAP's function in lymphocyte trafficking and immune surveillance. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
This cAMP analog acts as a second messenger, activating PKA and potentially promoting the effects of NKAP on transcriptional control. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
As an ionophore, A23187 increases intracellular calcium, thereby possibly enhancing NKAP's ability to regulate calcium-dependent transcription factors. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor could shift signaling pathways to enhance NKAP's regulatory activities in immune response modulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 might indirectly support NKAP's function in T-cell maturation and its interactions with other signaling proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
By inhibiting PI3K, Wortmannin could indirectly enhance NKAP's role in controlling signaling pathways related to immune cell function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, leading to increased cAMP levels and potentially augmenting NKAP's regulatory effects on transcription. | ||||||